Chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS): what do we know?
To dissertate about chronic prostatitis/chronic pelvic pain syndrome is, in the beginning of the XXI century, more difficult and complex than before. Indeed the therapeutical and pathogenetic hypothesis chase, below and often contradict each other. In this review we have tried to underline the opinions of the most accredited researcher, leaving to the reader the possibility to throw one's due conclusions.
Guercini
Federico
F
Urologic Department, Università di Perugia, Perugia, Italy.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy* / Q000209:etiology* / Q000382:microbiology; D016896:Treatment Outcome
D000317:Adrenergic alpha-Antagonists; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents